Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections

Scholarly Works

• Elanany, A. A.; Khalifa, A. G.; Attia, A. S. Antivirulence drugs against Acinetobacter baumannii: where do they stand?. World Journal of Microbiology and Biotechnology 2025, 41. doi:10.1007/s11274-025-04593-3
• Elanany, A. A.; Khalifa, A. G.; Attia, A. S. Antivirulence drugs against Acinetobacter baumannii: where do they stand?. World journal of microbiology & biotechnology 2025, 41, 424.
• Di Leo, R.; Crispino, E.; Cuffaro, D.; Maisetta, G.; Bertacca, A.; Bianchi, M.; Batoni, G.; Wushur, I.; Rahman, F. A.; Winberg, J.-O.; Sylte, I.; Rossello, A.; Nuti, E. Identification of novel N-benzyloxy-amino acid hydroxamates as inhibitors of the virulence factor LasB from Pseudomonas aeruginosa. RSC medicinal chemistry 2025, 16, 4973–4996. doi:10.1039/d5md00393h
• Wojtczak, K.; Gillon, E.; Bura, D.; Richmond, K.; Joyce, M.; Caraher, E.; Kessie, K.; Velasco-Torrijos, T.; Trujillo, C.; Imberty, A.; Kavanagh, K.; Cooke, G.; Byrne, J. P. Antiadhesive glycoconjugate metal complexes targeting pathogens Pseudomonas aeruginosa and Candida albicans. Organic & biomolecular chemistry 2025. doi:10.1039/d5ob00970g
• Yu, X.-Q.; Gong, Y.-W.; Tian, J.-Q.; Peng, C.; Niu, S.-M.; Feng, H.-Z.; You, C.-G.; Wang, Z.-P. Cross-talk between Pseudomonas aeruginosa and urinary tract infections. World journal of urology 2025, 43, 380. doi:10.1007/s00345-025-05758-3
• Thiemann, M.; Zimmermann, M.; Diederich, C.; Zhan, H.; Lebedev, M.; Pletz, J.; Baumgarten, J.; Handke, M.; Müsken, M.; Breinbauer, R.; Krasteva-Christ, G.; Zanin, E.; Empting, M.; Schiedel, M.; Kunick, C.; Blankenfeldt, W. From Bones to Bugs: Structure-Based Development of Raloxifene-Derived Pathoblockers That Inhibit Pyocyanin Production in Pseudomonas aeruginosa. Journal of medicinal chemistry 2025, 68, 7390–7420. doi:10.1021/acs.jmedchem.4c03065
• Wu, Y.; Wen, F.; Gou, S.; Ran, Q.; Chu, Y.; Ma, W.; Zhao, K. Multifaceted quorum-sensing inhibiting activity of 3-(Benzo[d][1,3]dioxol-4-yl)oxazolidin-2-one mitigates Pseudomonas aeruginosa virulence. Virulence 2025, 16, 2479103. doi:10.1080/21505594.2025.2479103
• Vazquez-Armenta, F. J.; Alvarez-Armenta, A.; Sugich-Miranda, R.; Ayala-Zavala, F.; Morales-Ortega, A.; Arvizu-Flores, A. A.; Lopez-Zavala, A. A. Inhibition Mechanism of Lecithin-Dependent Hemolysin from Vibrio parahaemolyticus by Flavonoids: An Enzyme Kinetic and Structural Approach. Catalysts 2025, 15, 257. doi:10.3390/catal15030257
• Chambial, P.; Thakur, N.; Bhukya, P. L.; Subbaiyan, A.; Kumar, U. Frontiers in superbug management: innovating approaches to combat antimicrobial resistance. Archives of microbiology 2025, 207, 60. doi:10.1007/s00203-025-04262-x
• Beshr, G.; Sikandar, A.; Gläser, J.; Fares, M.; Sommer, R.; Wagner, S.; Köhnke, J.; Titz, A. A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity. The Journal of biological chemistry 2024, 301, 108151. doi:10.1016/j.jbc.2024.108151
• Zahorska, E.; Denig, L. M.; Lienenklaus, S.; Kuhaudomlarp, S.; Tschernig, T.; Lipp, P.; Munder, A.; Gillon, E.; Minervini, S.; Verkhova, V.; Imberty, A.; Wagner, S.; Titz, A. High-Affinity Lectin Ligands Enable the Detection of Pathogenic Pseudomonas aeruginosa Biofilms: Implications for Diagnostics and Therapy. JACS Au 2024, 4, 4715–4728. doi:10.1021/jacsau.4c00670
• Baumgarten, J.; Schneider, P.; Thiemann, M.; Zimmermann, M.; Diederich, C.; Blankenfeldt, W.; Kunick, C. Substrate-Based Ligand Design for Phenazine Biosynthesis Enzyme PhzF. ChemMedChem 2024, 19, e202400466. doi:10.1002/cmdc.202400466
• Beshr, G.; Sikandar, A.; Gläser, J.; Fares, M.; Sommer, R.; Wagner, S.; Köhnke, J.; Titz, A. A fucose-binding superlectin fromEnterobacter cloacaewith high Lewis and ABO blood group antigen specificity. Cold Spring Harbor Laboratory 2024. doi:10.1101/2024.10.01.616118
• Metelkina, O.; Konstantinović, J.; Klein, A.; Shafiei, R.; Fares, M.; Alhayek, A.; Yahiaoui, S.; Elgaher, W. A. M.; Haupenthal, J.; Titz, A.; Hirsch, A. K. H. Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB. Chemical science 2024, 15, 13333–13342. doi:10.1039/d4sc02703e
• Chen, P.; Qin, J.; Su, H. K.; Du, L.; Zeng, Q. Harmine acts as a quorum sensing inhibitor decreasing the virulence and antibiotic resistance of Pseudomonas aeruginosa. BMC infectious diseases 2024, 24, 760. doi:10.1186/s12879-024-09639-9
• Anjum, F.; Hazazi, A.; Alsaeedi, F. A.; Bakhuraysah, M.; Shafie, A.; Alshehri, N. A.; Hawsawi, N.; Ashour, A. A.; Banjer, H. J.; Alharthi, A.; Niaz, M. I. Identification and Dynamics Understanding of Novel Inhibitors of Peptidase Domain of Collagenase G from Clostridium histolyticum. Computation 2024, 12, 153. doi:10.3390/computation12080153
• Butler, M. S.; Vollmer, W.; Goodall, E. C. A.; Capon, R. J.; Henderson, I. R.; Blaskovich, M. A. T. A Review of Antibacterial Candidates with New Modes of Action. ACS infectious diseases 2024, 10, 3440–3474. doi:10.1021/acsinfecdis.4c00218
• Moulding, P. B.; El-Halfawy, O. M. Chemical-mediated virulence: the effects of host chemicals on microbial virulence and potential new antivirulence strategies. Canadian journal of microbiology 2024, 70, 405–425. doi:10.1139/cjm-2024-0017
• Olaru, O. T.; Nitulescu, G. M.; Codreanu, A. M.; Calmuc, V.-A.; Venables, L.; van de Venter, M.; Gird, C. E.; Duta-Bratu, C.-G.; Nitulescu, G. Inhibitory Effects on Staphylococcus aureus Sortase A by Aesculus sp. Extracts and Their Toxicity Evaluation. Plants (Basel, Switzerland) 2024, 13, 1405. doi:10.3390/plants13101405
• Lobertti, C. A.; Gizzi, F. O.; Magni, C.; Rial, A.; Chabalgoity, J. A.; Yim, L.; Blancato, V. S.; Asquith, C. R. M.; García Véscovi, E. Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategy. Scientific reports 2024, 14, 5148. doi:10.1038/s41598-024-55793-0

Explore citations to this article at